Whitnell & Co’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$401K Hold
2,100
0.12% 122
2019
Q3
$353K Hold
2,100
0.12% 122
2019
Q2
$352K Hold
2,100
0.13% 109
2019
Q1
$307K Sell
2,100
-1,279
-38% -$185K 0.12% 115
2018
Q4
$452K Hold
3,379
0.2% 95
2018
Q3
$644K Hold
3,379
0.25% 79
2018
Q2
$563K Hold
3,379
0.23% 87
2018
Q1
$569K Hold
3,379
0.24% 86
2017
Q4
$553K Hold
3,379
0.23% 90
2017
Q3
$693K Hold
3,379
0.3% 84
2017
Q2
$821K Hold
3,379
0.36% 76
2017
Q1
$807K Hold
3,379
0.36% 77
2016
Q4
$710K Hold
3,379
0.33% 80
2016
Q3
$778K Hold
3,379
0.27% 78
2016
Q2
$781K Sell
3,379
-300
-8% -$69.2K 0.25% 83
2016
Q1
$986K Hold
3,679
0.37% 77
2015
Q4
$1.15M Hold
3,679
0.43% 69
2015
Q3
$1M Hold
3,679
0.39% 71
2015
Q2
$1.12M Hold
3,679
0.4% 71
2015
Q1
$1.09M Hold
3,679
0.41% 64
2014
Q4
$947K Hold
3,679
0.36% 75
2014
Q3
$888K Hold
3,679
0.35% 72
2014
Q2
$821K Hold
3,679
0.38% 84
2014
Q1
$757K Hold
3,679
0.35% 86
2013
Q4
$618K Hold
3,679
0.28% 94
2013
Q3
$530K Hold
3,679
0.26% 97
2013
Q2
$464K Buy
+3,679
New +$417K 0.23% 98

Other funds holding AGN

Whitnell & Co's AGN Position: Q4 2019 in Review

Whitnell & Co held its Allergan plc (AGN) position steady in Q4 2019 at 2,100 shares worth $401K. The position accounts for 0.12% of the portfolio, ranked #122.

Whitnell & Co first reported a position in AGN in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.15M in Q4 2015. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Whitnell & Co held 2,100 shares of Allergan plc worth $401K as of Q4 2019.
  • Whitnell & Co left its Allergan plc share count unchanged in Q4 2019.
  • Allergan plc made up 0.12% of Whitnell & Co's portfolio in Q4 2019, its #122 holding.
  • Whitnell & Co first reported a position in Allergan plc in Q2 2013 and has held it in 27 quarters since.
  • Whitnell & Co's Allergan plc position peaked at $1.15M in Q4 2015.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.